Clinical Utility of Pre-Therapeutic [18F]FDG PET/CT Imaging for Predicting Outcomes in Breast Cancer

Background: [18F]FDG PET/CT is used for staging and could also provide information associated with clinical outcomes. The objective of this study was to determine the clinical utility of biomarkers measured using [18F]FDG PET/CT to predict the absence of pathological complete response (no-pCR) and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Najid, Sophia, Seban, Romain-David, Champion, Laurence, De Moura, Alexandre, Sebbag, Clara, Salaün, Hélène, Cabel, Luc, Bonneau, Claire
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488013/
https://www.ncbi.nlm.nih.gov/pubmed/37685551
http://dx.doi.org/10.3390/jcm12175487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10488013/
https://www.ncbi.nlm.nih.gov/pubmed/37685551
http://dx.doi.org/10.3390/jcm12175487

Ejemplares similares